STUDY OF THE INTERACTION OF THE TRANSLUTAMINASINASE 2 WITH THE TRANSCRIPTION FACTOR P73 IN THE CONTEXT OF TUMOR FORMATION
- Autores: Gnennaya Y.A1, Piacentini M.2, Barlev N.A1
-
Afiliações:
- Institute of Cytology RAS
- University of Rome “Tor Vergata"
- Edição: Volume 15, Nº 3S (2020)
- Páginas: 86-86
- Seção: Articles
- ##submission.dateSubmitted##: 17.01.2023
- ##submission.datePublished##: 15.12.2020
- URL: https://genescells.ru/2313-1829/article/view/122794
- DOI: https://doi.org/10.23868/gc122794
- ID: 122794
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Texto integral
Sobre autores
Y. Gnennaya
Institute of Cytology RAS
Email: gnennaya1996@mail.ru
Saint-Petersburg, Russia
M. Piacentini
University of Rome “Tor Vergata"Rome, Italy
N. Barlev
Institute of Cytology RASSaint-Petersburg, Russia
Bibliografia
- Nezir A. E., Ulukan, B., Telci, D. Transglutaminase 2: The Maestro of the Oncogenic Mediators in Renal Cell Carcinoma. Medical Sciences. 2019; 7(2): 24;
- Tucholski, J. TG2 protects neuroblastoma cells against DNA-damage-induced stress, suppresses p53 activation. Amino Acids. 2010; 39(2): 523-532.
Arquivos suplementares
